Gene Set Enrichment Analysis (GSEA) revealed that hNSCs harboring TERT/CA-KRAS/DN-p53/ZDHHC17 showed a more obvious glioma signature than control hNSCs (Figure S7). This evidence concerns the gene TP53 and central nervous system cancer.